Key facts
- This page summarizes Mark Christopher Murray's Form 4 filing for Avantor, Inc. (AVTR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Jan 2022, 16:12.
Mark Christopher Murray - 13 Jan 2022 Form 4 Insider Report for Avantor, Inc. (AVTR)
- Reporting relationship
- EVP, Biomaterials & AT
- Issuer ticker
- AVTR
- Reported as of
- 13 Jan 2022
- Net transaction value
- -$34,425
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2022, 16:12:56 UTC
- Next SEC filing
- 17 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Scott Baker, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Christopher Murray filed Form 4 for Avantor, Inc. (AVTR) on 18 Jan 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$34,425.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVTR
transaction
Common Stock
Tax liability
- Transaction value
- $34,425
- Shares
- -918
- Change %
- -4.7%
- Price
- $37.50
- Shares after
- 18,680
- Date
- 13 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.